Bellerophon Therapeutics Probability of Future Pink Sheet Price Finishing Over 0.70
| BLPHDelisted Stock | USD 0.71 0.01 1.43% |
Bellerophon |
Bellerophon Therapeutics Target Price Odds to finish over 0.70
The tendency of Bellerophon Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.70 in 90 days |
| 0.71 | 90 days | 0.70 | about 82.93 |
Based on a normal probability distribution, the odds of Bellerophon Therapeutics to stay above $ 0.70 in 90 days from now is about 82.93 (This Bellerophon Therapeutics probability density function shows the probability of Bellerophon Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Bellerophon Therapeutics price to stay between $ 0.70 and its current price of $0.71 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days Bellerophon Therapeutics has a beta of -0.98 suggesting Additionally Bellerophon Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Bellerophon Therapeutics Price Density |
| Price |
Predictive Modules for Bellerophon Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bellerophon Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bellerophon Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bellerophon Therapeutics is not an exception. The market had few large corrections towards the Bellerophon Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bellerophon Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bellerophon Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.98 | |
β | Beta against Dow Jones | -0.98 | |
σ | Overall volatility | 3.90 | |
Ir | Information ratio | -0.18 |
Bellerophon Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bellerophon Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bellerophon Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bellerophon Therapeutics is not yet fully synchronised with the market data | |
| Bellerophon Therapeutics has some characteristics of a very speculative penny stock | |
| Bellerophon Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bellerophon Therapeutics currently holds about 16.33 M in cash with (17.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference |
Bellerophon Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bellerophon Pink Sheet often depends not only on the future outlook of the current and potential Bellerophon Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bellerophon Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.6 M | |
| Cash And Short Term Investments | 6.9 M |
Bellerophon Therapeutics Technical Analysis
Bellerophon Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Bellerophon Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bellerophon Therapeutics. In general, you should focus on analyzing Bellerophon Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Bellerophon Therapeutics Predictive Forecast Models
Bellerophon Therapeutics' time-series forecasting models is one of many Bellerophon Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bellerophon Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Bellerophon Therapeutics
Checking the ongoing alerts about Bellerophon Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bellerophon Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bellerophon Therapeutics is not yet fully synchronised with the market data | |
| Bellerophon Therapeutics has some characteristics of a very speculative penny stock | |
| Bellerophon Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bellerophon Therapeutics currently holds about 16.33 M in cash with (17.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |